These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2475397)

  • 1. Fluorescence crossmatch testing.
    Prazák J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):193-8. PubMed ID: 2475397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences in thrombocyte substitution following bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen D; Mahmoud HK; Schmidt CG
    Beitr Infusionther Klin Ernahr; 1986; 15():165-71. PubMed ID: 3530241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO blood groups and platelet transfusion].
    Eckstein R; Zeiler T; Zingsem J; Heuft HG; Musch R; Weisbach V
    Beitr Infusionsther; 1990; 26():157-9. PubMed ID: 1703819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 11. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selection of HLA compatible thrombocyte donors using electronic data processing with a newly developed score].
    König AL; Holzer M
    Beitr Infusionsther; 1990; 26():163-7. PubMed ID: 1703821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of HLA antibody formation in patients with hemato-oncologic diseases by using leukocyte depleted blood preparations].
    Adamzik ID; Jin J; Sachs V; Thomsen H
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):9-13. PubMed ID: 7727966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic composition of 94 consecutive Danish families investigated with respect to bone marrow transplantation.
    Christiansen SE; Jørgensen F; Kristensen T; Lamm LU; Hansen PW; Kissmeyer-Nielsen F
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):239-44. PubMed ID: 2939600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe aplastic anemia treated with HLA-matched platelet transfusion].
    Nozaki H; Yonekura S; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1986 Aug; 27(8):1410-4. PubMed ID: 3795515
    [No Abstract]   [Full Text] [Related]  

  • 17. The present status of blood component therapy in the United States.
    Schiffer CA
    Rinsho Ketsueki; 1978 Oct; 19(10):1467-73. PubMed ID: 368374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet and granulocyte transfusion in hematology].
    Ouellet P
    Union Med Can; 1983 May; 112(5):457-60. PubMed ID: 6879858
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J; Hooi C; Garvey MB
    Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of a 51Cr platelet lysis assay as crossmatch test in patients with leukaemia on platelet transfusion therapy.
    van der Velden KJ; Sintnicolaas K; Löwenberg B
    Br J Haematol; 1986 Apr; 62(4):635-40. PubMed ID: 3964557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.